Evidence map›Paper›PMID 29565665›Full record

ArticleAmerican journal of public health2018

Rising Trends of Prescription Opioid Sales in Contemporary Brazil, 2009-2015.

Noa Krawczyk, M Claire Greene, Rafaela Zorzanelli, Francisco I Bastos

Abstract read
In one paragraph

Article in American journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Inappropriate opioid prescription after surgery.Lancet (London, England) · 2019
    Review
  18. World Opioid and Substance Use Epidemic: A Latin American Perspective.Psychiatric research and clinical practice · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Noa KrawczykNoa Krawczyk and M. Claire Greene are with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Rafaela Zorzanelli is with the Social Medicine Institute of the State University of Rio de Janeiro, Rio de Janeiro, Brazil. Francisco I. Bastos is with the FIOCRUZ-Oswaldo Cruz Foundation, Rio de Janeiro.
M Claire GreeneNoa Krawczyk and M. Claire Greene are with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Rafaela Zorzanelli is with the Social Medicine Institute of the State University of Rio de Janeiro, Rio de Janeiro, Brazil. Francisco I. Bastos is with the FIOCRUZ-Oswaldo Cruz Foundation, Rio de Janeiro.
Rafaela ZorzanelliNoa Krawczyk and M. Claire Greene are with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Rafaela Zorzanelli is with the Social Medicine Institute of the State University of Rio de Janeiro, Rio de Janeiro, Brazil. Francisco I. Bastos is with the FIOCRUZ-Oswaldo Cruz Foundation, Rio de Janeiro.
Francisco I BastosNoa Krawczyk and M. Claire Greene are with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Rafaela Zorzanelli is with the Social Medicine Institute of the State University of Rio de Janeiro, Rio de Janeiro, Brazil. Francisco I. Bastos is with the FIOCRUZ-Oswaldo Cruz Foundation, Rio de Janeiro.

Funding

NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
POSTDOCTORAL TRAINING PROGRAM IN SAS PREVENTIONT32DA007293 · NIDA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MERMELSTEIN, ROBIN J. · 1993 to 2008
$2.4M
NIDA NIH HHS T32 DA007292NIDA NIH HHS T32 DA007293
6 · The paper itself

Abstract

objectivesTo present and discuss recent patterns of prescription opioid sales throughout Brazil.

methodsWe graphed linear trends of opioid prescriptions sold from registered pharmacies across Brazil from 2009 to 2015. We then calculated the change in rate of prescriptions sold per 1000 persons in 2015 compared with 2009.

resultsOpioid sales increased across Brazil from 1 601 043 prescriptions in 2009 to 9 045 945 prescriptions in 2015, corresponding to a 465% increase in 6 years. The largest absolute increase was for codeine products (rate ratio (RR) = 5.30; 95% confidence interval [CI] = 5.29, 5.31), accounting for more than 98% of prescriptions in both years. Oxycodone had the largest relative increase (RR = 11.39; 95% CI = 11.19, 11.59), and fentanyl products had the smallest absolute and relative increase (RR = 2.91; 95% CI = 2.78, 3.03).

conclusionsGiven rapid increases in opioid sales across Brazil, it is critical to introduce effective prescribing and monitoring methods that allow patients to access necessary medications without escalating risk of opioid misuse and related consequences. Careful surveillance of supply and subsequent outcomes are needed to prevent the development of another devastating opioid epidemic in the Americas.

Indexed as

Analgesics, OpioidBrazilDrug PrescriptionsHumansPharmaciesAnalgesics, Opioid

Identifiers

PMID29565665
PMCPMC5888056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.